Related Experiment Videos
Oxidative stress in essential hypertension
F Portaluppi1, B Boari, R Manfredini
1Hypertension Center, Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy. prf@unife.it
Current Pharmaceutical Design
|May 12, 2004
Summary
Essential hypertension impairs nitric oxide (NO) availability, leading to endothelial dysfunction and target organ damage. Restoring NO bioavailability may offer prognostic benefits beyond blood pressure reduction in hypertensive patients.
Area of Science:
- Cardiovascular Medicine
- Endothelial Biology
- Hypertension Research
Background:
- Essential hypertension is linked to endothelial dysfunction, primarily due to reduced nitric oxide (NO) availability.
- Oxidative stress, stemming from altered redox balance and increased superoxide anion production in endothelial cells, exacerbates vascular dysfunction.
- This dysfunction contributes to hypertensive target organ damage through mechanisms like platelet activation and leukocyte adhesion.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) bioavailability in essential hypertension.
- To explore the potential therapeutic benefits of restoring NO availability in hypertensive patients.
- To assess whether improved NO bioavailability offers prognostic advantages beyond blood pressure reduction.
Main Methods:
- The study reviews mechanisms affecting NO synthesis and breakdown in essential hypertension.
- It examines the impact of oxidative stress on endothelial function and vascular tone.
- Existing literature on antihypertensive therapies and their effects on NO bioavailability is analyzed.
Main Results:
- Decreased NO availability is a key factor in endothelial dysfunction in essential hypertension.
- Oxidative stress and increased superoxide anion production play a significant role in pathogenesis.
- Current antihypertensive drugs, except for some renin-angiotensin system antagonists and calcium-channel blockers, have not been extensively studied for their ability to restore NO bioavailability.
Conclusions:
- Restoring NO availability in essential hypertension could provide benefits beyond blood pressure control, potentially preventing target organ damage.
- Further longitudinal studies are needed to confirm if antihypertensive treatments that restore NO bioavailability offer additional prognostic advantages.